Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.87B |
| 2 |
NVIDIA
NVDA
|
+$2.46B |
| 3 |
Microsoft
MSFT
|
+$1.32B |
| 4 |
Amazon
AMZN
|
+$1.13B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.78B |
| 2 |
SNDK
Sandisk
SNDK
|
+$949M |
| 3 |
Advanced Micro Devices
AMD
|
+$926M |
| 4 |
Micron Technology
MU
|
+$585M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$509M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Communication Services | 0.62% |
| 3 | Consumer Discretionary | 0.62% |
| 4 | Industrials | 0.48% |
| 5 | Healthcare | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HIX
12101
Western Asset High Income Fund II
HIX
$355M
| $169K | ﹤0.01% |
42,791
+20,144
| +89% | +$80K |
|
12102
PUT
Adicet Bio
ACET
$86M
| $169K | ﹤0.01% |
+19,600
| New | +$154K |
|
12103
Orion Group Holdings
ORN
$375M
| $169K | ﹤0.01% |
10,054
-3,598
| -26% | -$49.7K |
|
12104
CALL
iHeartMedia
IHRT
$432M
| $169K | ﹤0.01% |
39,400
-12,100
| -23% | -$53.6K |
|
|
TQQY
12105
GraniteShares YieldBOOST QQQ ETF
TQQY
$6.23M
| $169K | ﹤0.01% |
+12,986
| New | +$173K |
|
|
CSCS
12106
Direxion Daily CSCO Bear 1X ETF
CSCS
$1.72M
| $168K | ﹤0.01% |
+12,740
| New | +$200K |
|
|
BEBE
12107
TGE Value Creative Solutions Corp
BEBE
$200M
| $168K | ﹤0.01% |
+16,858
| New | +$167K |
|
12108
BlackRock Energy and Resources Trust
BGR
$444M
| $168K | ﹤0.01% |
+11,338
| New | +$181K |
|
12109
Nuveen Multi-Market Income Fund
JMM
$54.6M
| $168K | ﹤0.01% |
28,650
+3,987
| +16% | +$23.2K |
|
|
LFT
12110
Lument Finance Trust
LFT
$35M
| $168K | ﹤0.01% |
182,226
+164,996
| +958% | +$188K |
|
|
BSAA
12111
BEST SPAC I Acquisition Corp
BSAA
$88.8M
| $167K | ﹤0.01% |
14,437
+520
| +4% | +$6.07K |
|
|
DDL
12112
CALL
Dingdong
DDL
$540M
| $167K | ﹤0.01% |
86,700
-7,700
| -8% | -$19.1K |
|
12113
Compugen
CGEN
$248M
| $167K | ﹤0.01% |
78,141
+67,477
| +633% | +$169K |
|
12114
Bioventus
BVS
$982M
| $167K | ﹤0.01% |
17,692
-3,525
| -17% | -$33.7K |
|
12115
CALL
Fate Therapeutics
FATE
$279M
| $167K | ﹤0.01% |
61,800
+11,300
| +22% | +$20.9K |
|
12116
PUT
Protalix BioTherapeutics
PLX
$192M
| $167K | ﹤0.01% |
71,600
+11,900
| +20% | +$25.2K |
|
12117
CALL
TaskUs
TASK
$733M
| $167K | ﹤0.01% |
35,600
-6,500
| -15% | -$39.4K |
|
12118
CALL
Lifecore Biomedical
LFCR
$172M
| $166K | ﹤0.01% |
+31,700
| New | +$160K |
|
12119
PUT
AC Immune
ACIU
$288M
| $166K | ﹤0.01% |
69,900
+44,300
| +173% | +$122K |
|
12120
CALL
Microbot Medical
MBOT
$101M
| $166K | ﹤0.01% |
85,300
+73,000
| +593% | +$149K |
|
12121
CALL
ProShares Short Russell2000
RWM
$111M
| $166K | ﹤0.01% |
12,500
-63,900
| -84% | -$919K |
|
12122
PUT
Amplitude
AMPL
$1.66B
| $166K | ﹤0.01% |
21,700
-27,100
| -56% | -$187K |
|
|
CEGX
12123
Tradr 2X Long CEG Daily ETF
CEGX
$18.3M
| $166K | ﹤0.01% |
14,239
-12,308
| -46% | -$193K |
|
|
MPG
12124
Leverage Shares 2X Long MP Daily ETF
MPG
$6.88M
| $166K | ﹤0.01% |
+27,958
| New | +$212K |
|
|
BMNU
12125
T-REX 2X Long BMNR Daily Target ETF
BMNU
$364M
| $165K | ﹤0.01% |
24,752
-132,749
| -84% | -$2.13M |
|
Similar funds
Jeff Yass's Q2 2026 Portfolio in Review
As of Q2 2026, Jeff Yass held 15,023 positions worth $1.28T, up 44% from $893B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $142B of net new capital in Q2 2026, opening 1,956 new positions and adding to 5,793 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, up from 2% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.78B trimmed.
- Jeff Yass's largest Q2 2026 buy was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.87B increase.
- Jeff Yass's biggest Q2 2026 reduction was Invesco QQQ Trust, cutting an estimated $1.78B.
- Jeff Yass fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $142M.
- Jeff Yass's ten largest holdings make up 27% of its $1.28T portfolio in Q2 2026.
- Jeff Yass opened 1,956 new positions and closed 1,748 in Q2 2026.
- Jeff Yass's portfolio value rose 44% quarter-over-quarter to $1.28T.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.